Blood test targets ‘Achilles’ heel’ of CRC screening, detects 81% of advanced adenomas

Researchers have developed a blood-based assay that could help identify individuals with precursor lesions for colorectal cancer, a known limitation of many blood-based screening tests.The assay, known as DENEB, detected 81% of advanced adenomas, as well as 91% of CRC overall and 92% of stage I to III cancers.